174 related articles for article (PubMed ID: 7962125)
21. Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme.
Fridman R; Bird RE; Hoyhtya M; Oelkuct M; Komarek D; Liang CM; Berman ML; Liotta LA; Stetler-Stevenson WG; Fuerst TR
Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):411-6. PubMed ID: 8380993
[TBL] [Abstract][Full Text] [Related]
22. The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor.
Kolkenbrock H; Orgel D; Hecker-Kia A; Noack W; Ulbrich N
Eur J Biochem; 1991 Jun; 198(3):775-81. PubMed ID: 1646720
[TBL] [Abstract][Full Text] [Related]
23. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
[TBL] [Abstract][Full Text] [Related]
24. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation.
Benyon RC; Hovell CJ; Da Gaça M; Jones EH; Iredale JP; Arthur MJ
Hepatology; 1999 Oct; 30(4):977-86. PubMed ID: 10498650
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2.
Howard EW; Bullen EC; Banda MJ
J Biol Chem; 1991 Jul; 266(20):13064-9. PubMed ID: 2071592
[TBL] [Abstract][Full Text] [Related]
26. Expression of matrix metalloproteinase -2, -9 and tissue inhibitors of metalloproteinase -1, -2, -3 mRNAs in rat uterus during early pregnancy.
Zhao YG; Xiao AZ; Cao XM; Zhu C
Mol Reprod Dev; 2002 Jun; 62(2):149-58. PubMed ID: 11984824
[TBL] [Abstract][Full Text] [Related]
27. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
Shapiro SD; Fliszar CJ; Broekelmann TJ; Mecham RP; Senior RM; Welgus HG
J Biol Chem; 1995 Mar; 270(11):6351-6. PubMed ID: 7890773
[TBL] [Abstract][Full Text] [Related]
28. What structure and function of avian plasminogen activator and matrix metalloproteinase-2 reveal about their counterpart mammalian enzymes, their regulation and their role in tumor invasion.
Alexander DS; Aimes RT; Quigley JP
Enzyme Protein; 1996; 49(1-3):38-58. PubMed ID: 8796996
[TBL] [Abstract][Full Text] [Related]
29. Expression of 72-kDa gelatinase and TIMP-2 in early and late passage human fibroblasts.
Zeng G; Millis AJ
Exp Cell Res; 1994 Jul; 213(1):148-55. PubMed ID: 8020585
[TBL] [Abstract][Full Text] [Related]
30. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
Goldberg GI; Collier IE; Eisen AZ; Grant GA; Marmer BL; Wilhelm SM
Matrix Suppl; 1992; 1():25-30. PubMed ID: 1336109
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts.
Overall CM; Wrana JL; Sodek J
Connect Tissue Res; 1989; 20(1-4):289-94. PubMed ID: 2558843
[TBL] [Abstract][Full Text] [Related]
33. The extracellular matrix produced by bovine corneal endothelial cells contains progelatinase A.
Menashi S; Vlodavsky I; Ishai-Michaeli R; Legrand Y; Fridman R
FEBS Lett; 1995 Mar; 361(1):61-4. PubMed ID: 7890041
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
[TBL] [Abstract][Full Text] [Related]
35. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
[TBL] [Abstract][Full Text] [Related]
36. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y
Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498
[TBL] [Abstract][Full Text] [Related]
37. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
Moll UM; Youngleib GL; Rosinski KB; Quigley JP
Cancer Res; 1990 Oct; 50(19):6162-70. PubMed ID: 2169335
[TBL] [Abstract][Full Text] [Related]
38. Serine protease and metallo protease cascade systems involved in pericellular proteolysis.
Quigley JP; Berkenpas MB; Aimes RT; Chen JM
Cell Differ Dev; 1990 Dec; 32(3):263-75. PubMed ID: 1965954
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of metalloproteinase (gelatinase) activity secreted from Rous sarcoma virus-infected cells correlates with transforming activity of src.
Hamaguchi M; Yamagata S; Thant AA; Xiao H; Iwata H; Mazaki T; Hanafusa H
Oncogene; 1995 Mar; 10(6):1037-43. PubMed ID: 7535415
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts.
Goldfarb RH; Quigley JP
Cancer Res; 1978 Dec; 38(12):4601-9. PubMed ID: 214228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]